Advertisement

Topics

Early NLR Changes Predict mRCC Immunotherapy Outcomes

08:45 EDT 11 Sep 2017 | American Society of Nephrology

Rises and decreases in neutrophil-to-lymphocyte ratio at 6 weeks after treatment with anti-PD-1/PD-L1 immune checkpoint blockade is associated with progression-free and overall survival.

Original Article: Early NLR Changes Predict mRCC Immunotherapy Outcomes

NEXT ARTICLE

More From BioPortfolio on "Early NLR Changes Predict mRCC Immunotherapy Outcomes"

Quick Search
Advertisement